Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AllergenIQ is a digital health company specializing in comprehensive, virtual-first allergy care and management. Founded by board-certified allergists, the company offers a platform that connects patients with specialists to treat food allergies, asthma, eczema, and environmental allergies. Their service model includes personalized treatment plans, such as Oral Immunotherapy (OIT) support, and utilizes remote monitoring to improve patient safety and outcomes. AllergenIQ focuses on expanding access to expert care through a convenient, technology-driven approach for families and individuals. The platform serves as an "Allergy Medical Home," providing continuous support, education, and clinical oversight for chronic allergic conditions. By leveraging telemedicine, the company aims to reduce the wait times and geographic barriers typically associated with seeing an allergy specialist.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AllergenIQ.